|Bid||0.0000 x 4000|
|Ask||0.0000 x 1400|
|Day's Range||4.2120 - 4.4900|
|52 Week Range||1.0800 - 4.9300|
|Beta (5Y Monthly)||0.97|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Dogecoin (CRYPTO: DOGE), in many ways, is at the epicenter of the cryptocurrency craze. In fact, Dogecoin's price has fallen by more than 58% from its recent highs, implying that the rampant enthusiasm that drove the coin's price through the roof earlier this year may be waning, perhaps for good. The good news is that there are a handful of biotech penny stocks (equities with a sub-$5 share price) capable of delivering jaw-dropping returns for risk-tolerant investors.
Let’s talk about growth stocks. These are stocks that have shown strong and sustained share price appreciation, sometimes ranging into triple-digit gains over the course of a year or more. In short, these are stocks that make investors say, “If only I’d bought in when…!” There’s no point dwelling on the past. A savvy investor, aiming to build a growth-oriented portfolio, will set up a profile for a solid growth stock, and look to match it. The factors to look for: that strong appreciation we men
Verastem (VSTM) has moved higher as of late, but there could definitely be trouble on the horizon for this company.